Table 3.
Specificity of intraepithelial lymphocytes profiling in the diagnosis of celiac disease.
| uCD Median (IQR) |
GFD-CD Median (IQR) |
I-controls Median (IQR) |
C-controls Median (IQR) |
|
|---|---|---|---|---|
| Total IELs | 16.80% (4.80) | 10.40% (4.11) | 10.70% (3.70) | 8.50% (2.60) |
| Non-T cells | 3.10% (4.00) | 9.34% (3.34) | 16.30% (8.12) | 28.90% (15.75) |
| TCRγδ+cells | 35.78% (11.13) | 32.50% (8.90) | 7.51% (2.60) | 6.44% (2.38) |
| TCRαβ+cells | 59.30% (15,6) | 58.80% (10,9) | 76.20% (8,9) | 62.10% (14,5) |
Percentages of duodenal Intraepithelial lymphocyte (IEL) populations in untreated Celiac Disease (uCD), Gluten Free Diet-CD patients (GFD-CD), inflamed non-CD controls (I-controls) and non-inflamed non-CD controls (C-controls) expressed as median percentages with the interquartile range (IQR).